Dose - response relationship of bevacizumab in hereditary hemorrhagic telangiectasia
Auteurs | Azzopardi N, Dupuis-Girod S, Ternant D, Fargeton AE, Ginon I, Faure F, Decullier E, Roux A, Carette MF, Gilbert-Dussardier B, Hatron PY, Lacombe P, Leguy-Seguin V, Riviere S, Corre R, Bailly S, Paintaud G |
Revue | |
Institut | iRTSV |
Année | 2 015 |